Amarin Corporation plc(AMRN)

Description: Amarin Corporation plc, a biopharmaceutical company, focuses on the development and commercialization therapeutic products for the treatment for cardiovascular diseases. Its product development program areas include lipid science and therapeutic benefits of polyunsaturated fatty acids. The company lead product comprises Vascepa, a prescription-only omega-3 fatty acid comprising icosapent ethyl as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. It also engages in developing Vascepa for the treatment of patients with high triglyceride levels who are also on statin therapy for elevated low-density lipoprotein cholesterol levels. The company was formerly known as Ethical Holdings plc. Amarin Corporation plc was founded in 1989 and is headquartered in Dublin, Ireland.

---

Keywords: Biopharmaceutical Organic Compounds Nutrition Acid Cardiovascular Disease Therapeutic Products Lipid Cholesterol Vascular Disease Fatty Acids Lipoprotein Low Density Lipoprotein Hypertriglyceridemia Triglyceride Severe Hypertriglyceridemia Amarin Corporation Ethyl Eicosapentaenoic Acid Polyunsaturated Fat Saturated Fat Statin Therapy

---

Home Page: www.amarincorp.com

AMRN Technical Analysis

Grand Canal Docklands
Dublin, 2
Ireland
Phone: 353 1 669 9020

---

Officers

Exchange: NASDAQ

Country: US : United States of America

Currency: US Dollar ($)